AIM: This systematic review evaluated the effects of telehome monitoring-based telenursing (THMTN) on health outcomes and use of healthcare services and compared them with the effects of conventional treatment in patients with severe and very severe chronic obstructive pulmonary disease (COPD). METHODS: An extensive published work search of several databases was performed in May and October 2011. Randomized controlled trials and non-randomized controlled clinical trials were evaluated. Parameters included hospitalization rate, number of visits to the emergency department, exacerbations, mean number of hospitalizations, mean duration of bed days of care, mortality, and health-related quality of life by the duration of THMTN and COPD severity. A random effects model was applied. Risk ratio and mean difference were calculated. Heterogeneity was assessed using the I(2) statistic. RESULTS: Nine original articles involving 550 participants were identified in the meta-analysis. THMTN decreased hospitalization rates, emergency department visits, exacerbations, mean number of hospitalizations, and mean duration of bed days of care in severe and very severe COPD patients. Hospitalization rates and emergency department visits were comparable between patients undergoing THMTN of different durations. In addition, THMTN had no effect on mortality. CONCLUSION: THMTN significantly decreases the use of healthcare services; however, it does not affect mortality in severe and very severe COPD patients.
AIM: This systematic review evaluated the effects of telehome monitoring-based telenursing (THMTN) on health outcomes and use of healthcare services and compared them with the effects of conventional treatment in patients with severe and very severe chronic obstructive pulmonary disease (COPD). METHODS: An extensive published work search of several databases was performed in May and October 2011. Randomized controlled trials and non-randomized controlled clinical trials were evaluated. Parameters included hospitalization rate, number of visits to the emergency department, exacerbations, mean number of hospitalizations, mean duration of bed days of care, mortality, and health-related quality of life by the duration of THMTN and COPD severity. A random effects model was applied. Risk ratio and mean difference were calculated. Heterogeneity was assessed using the I(2) statistic. RESULTS: Nine original articles involving 550 participants were identified in the meta-analysis. THMTN decreased hospitalization rates, emergency department visits, exacerbations, mean number of hospitalizations, and mean duration of bed days of care in severe and very severe COPDpatients. Hospitalization rates and emergency department visits were comparable between patients undergoing THMTN of different durations. In addition, THMTN had no effect on mortality. CONCLUSION:THMTN significantly decreases the use of healthcare services; however, it does not affect mortality in severe and very severe COPDpatients.
Authors: Ahmed Al Rajeh; Michael C Steiner; Yousef Aldabayan; Abdulelah Aldhahir; Elisha Pickett; Shumonta Quaderi; John R Hurst Journal: BMJ Open Respir Res Date: 2019-02-18
Authors: Ahmed M Alrajeh; Yousef S Aldabayan; Abdulelah M Aldhair; Elisha Pickett; Shumonta A Quaderi; Jaber S Alqahtani; Marc Lipman; John R Hurst Journal: Int J Chron Obstruct Pulmon Dis Date: 2019-08-01
Authors: Thorbjørn L Gregersen; Allan Green; Ejvind Frausing; Thomas Ringbæk; Eva Brøndum; Charlotte Suppli Ulrik Journal: Int J Chron Obstruct Pulmon Dis Date: 2016-04-21
Authors: Domingo Orozco-Beltran; Manuel Sánchez-Molla; Julio Jesus Sanchez; José Joaquin Mira Journal: J Med Internet Res Date: 2017-12-15 Impact factor: 5.428